DK3228631T3 - Behandling af respiratoriske tilstande - Google Patents

Behandling af respiratoriske tilstande Download PDF

Info

Publication number
DK3228631T3
DK3228631T3 DK17171064.3T DK17171064T DK3228631T3 DK 3228631 T3 DK3228631 T3 DK 3228631T3 DK 17171064 T DK17171064 T DK 17171064T DK 3228631 T3 DK3228631 T3 DK 3228631T3
Authority
DK
Denmark
Prior art keywords
treatment
respiratory conditions
respiratory
conditions
Prior art date
Application number
DK17171064.3T
Other languages
English (en)
Inventor
Graham Cotton
Ola Winqvist
Original Assignee
Tla Targeted Immunotherapies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tla Targeted Immunotherapies Ab filed Critical Tla Targeted Immunotherapies Ab
Application granted granted Critical
Publication of DK3228631T3 publication Critical patent/DK3228631T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3618—Magnetic separation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK17171064.3T 2011-06-13 2012-06-13 Behandling af respiratoriske tilstande DK3228631T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496377P 2011-06-13 2011-06-13
EP12727921.4A EP2718313B1 (en) 2011-06-13 2012-06-13 Treating respiratory conditions

Publications (1)

Publication Number Publication Date
DK3228631T3 true DK3228631T3 (da) 2020-09-28

Family

ID=46317442

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12727921.4T DK2718313T3 (da) 2011-06-13 2012-06-13 Behandling af respiratoriske tilstande
DK17171064.3T DK3228631T3 (da) 2011-06-13 2012-06-13 Behandling af respiratoriske tilstande

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12727921.4T DK2718313T3 (da) 2011-06-13 2012-06-13 Behandling af respiratoriske tilstande

Country Status (4)

Country Link
EP (2) EP2718313B1 (da)
DK (2) DK2718313T3 (da)
ES (2) ES2821375T3 (da)
WO (1) WO2012172346A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190187A1 (ar) 2017-02-03 2019-08-01 Novartis Ag مترافقات عقار جسم مضاد لـ ccr7

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050088A2 (en) * 1999-02-22 2000-08-31 Millennium Pharmaceuticals, Inc. Biotinylated-chemokine antibody complexes
US6723538B2 (en) * 1999-03-11 2004-04-20 Micromet Ag Bispecific antibody and chemokine receptor constructs
US6794132B2 (en) * 1999-10-02 2004-09-21 Biosite, Inc. Human antibodies
US6680209B1 (en) * 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
AU2003287949A1 (en) * 2002-09-23 2004-04-08 Rmf Dictagene S.A. Synthetic chemokines labeled at selected positions
JP4845873B2 (ja) * 2004-03-03 2011-12-28 ケモセントリックス インコーポレーティッド 二環式および架橋した窒素複素環
DE102005036505A1 (de) * 2004-07-30 2006-06-01 Adexter Gmbh Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung zur Behandlung von Krankheiten des Menschen
WO2006125201A2 (en) * 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
TW200800895A (en) * 2005-11-02 2008-01-01 Astrazeneca Ab Novel compounds
US8449489B2 (en) * 2006-05-12 2013-05-28 Ith Immune Therapy Holdings Ab Method and means for treating inflammatory bowel disease
MX2011001911A (es) * 2008-08-18 2011-07-04 Pfizer Anticuerpos para ccr2.
WO2010029317A2 (en) * 2008-09-10 2010-03-18 Ibd Column Therapies International Ab Treating inflammatory conditions

Also Published As

Publication number Publication date
WO2012172346A3 (en) 2013-03-14
DK2718313T3 (da) 2017-08-28
ES2821375T3 (es) 2021-04-26
ES2637390T3 (es) 2017-10-13
EP3228631A2 (en) 2017-10-11
WO2012172346A2 (en) 2012-12-20
EP2718313A2 (en) 2014-04-16
EP3228631A3 (en) 2018-01-10
EP3228631B1 (en) 2020-06-24
EP2718313B1 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
DK2785349T4 (da) Kombinationsbehandling af cancer
DK2717941T3 (da) Behandling af cancer
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2846809T3 (da) Behandling af myelosuppression
CO6811828A2 (es) Nebulizador
CO7010824A2 (es) Inhibidores de aplicación viral
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
DK2968208T3 (da) Behandling af kataplexi
BR112013032887A2 (pt) cateter
DK2701733T3 (da) Forbindelser til behandling af neuropsykiatriske forstyrrelser
DK3117862T3 (da) Åndedrætsmaske
CO6960555A2 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
DK3581199T3 (da) Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis
BR112014013850A2 (pt) conjunto de prateleiras
DK2906580T3 (da) Behandling af amyotrofisk lateral sklerose
BR112013025721A2 (pt) métodos de fabricação de elementos absorventes volumosos
DK2900259T3 (da) Glycosidase-regime til behandling af infektionssygdomme
DK2501381T3 (da) Behandling af atrieflimmer
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
DK3132684T3 (da) Behandling af fiskepopulationer med lufenuron
DK2673363T3 (da) Behandling af angiogenesesygdomme
DK2838850T3 (da) Oprensning af titantetrachlorid
DK2916922T3 (da) Behandling af alkalisk bauxitrest
DK2825636T3 (da) Behandling af sædceller
DK2780003T3 (da) Behandling af binyrebarkinsufficiens